Search Results - Katja G. Schmidt

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Safety, tolerability and clinical effects of rovunaptabin, also known as BC007 on fatigue and quality of life in patients with Post-COVID syndrome (reCOVer): a prospective, exploratory, placebo-controlled, double-blind, randomised phase IIa clinical trial (RCT)Research in context

    Safety, tolerability and clinical effects of rovunaptabin, also known as BC007 on fatigue and quality of life in patients with Post-COVID syndrome (reCOVer): a prospective, explora... by Bettina Hohberger, Marion Ganslmayer, Thomas Harrer, Friedrich Kruse, Stefanie Maas, Tobias Borst, Ralph Heimke-Brinck, Andreas Stog, Thomas Knauer, Eva Rühl, Victoria Zeisberg, Adam Skornia, Alexander Bartsch, Armin Ströbel, Monika Wytopil, Caroline Merkel, Sophia Hofmann, Katja G. Schmidt, Petra Lakatos, Julia Schottenhamml, Martin Herrmann, Christian Mardin, Jürgen Rech

    Published 2025-08-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Serum extracellular matrix biomarkers in rheumatoid arthritis, psoriatic arthritis and psoriasis and their association with hand function

    Serum extracellular matrix biomarkers in rheumatoid arthritis, psoriatic arthritis and psoriasis and their association with hand function by Helena Port, Birte Coppers, Sonja Tragl, Eva Manger, Lisa M. Niemiec, Sara Bayat, David Simon, Filippo Fagni, Giulia Corte, Anne-Christine Bay-Jensen, Koray Tascilar, Axel J. Hueber, Katja G. Schmidt, Verena Schönau, Michael Sticherling, Simon Heinrich, Sigrid Leyendecker, Daniela Bohr, Georg Schett, Arnd Kleyer, Signe Holm Nielsen, Anna-Maria Liphardt

    Published 2025-04-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: